The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
NCT03692182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2019-09-10
Summary
The aim of this study is to retrospectively evaluate and describe the use of antipsychotics among participants enrolled in the Program of All-inclusive Care for the Elderly (PACE), a community-based practice setting.
Conditions
- Behavioral and Psychiatric Symptoms of Dementia
Sponsors & Collaborators
-
Tabula Rasa HealthCare
lead INDUSTRY
Principal Investigators
-
Kevin T Bain, PharmD, MPH · Tabula Rasa HealthCare
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-12-31
- Completion
- 2019-03-31
Countries
- United States
Study Locations
More Related Trials
-
Optimisation of Antipsychotic Drug Use in Older People
NCT01454453 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396 ·Status: COMPLETED ·Phase: PHASE4
-
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
NCT00485498 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic
NCT02007928 ·Status: COMPLETED ·Phase: NA
-
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia
NCT01829048 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Olanzapine in Patients With Schizophrenia
NCT00970281 ·Status: COMPLETED ·Phase: PHASE3
-
Characterizing Response to Antipsychotics in Schizophrenia
NCT06159322 ·Status: RECRUITING
-
"Extended" (Alternate Day) Antipsychotic Dosing
NCT04478838 ·Status: RECRUITING ·Phase: PHASE4
-
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults
NCT01429740 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
NCT01609153 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed
NCT00618748 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00103571 ·Status: COMPLETED ·Phase: PHASE4
-
Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia
NCT02918825 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia
NCT01043458 ·Status: COMPLETED ·Phase: PHASE1
-
Amisulpride Treatment for BPSD in AD Patients
NCT04341467 ·Status: UNKNOWN ·Phase: NA
-
Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
NCT00183612 ·Status: TERMINATED ·Phase: NA
-
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
NCT00423878 ·Status: COMPLETED ·Phase: PHASE4
-
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
NCT00501618 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
NCT02704962 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects
NCT01952132 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
NCT00510211 ·Status: COMPLETED
-
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
NCT00036088 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter, Open-label, Safety and Tolerability Study
NCT01649557 ·Status: COMPLETED ·Phase: PHASE2
-
Olanzapine Treatment of Patients With Bipolar I Disorder
NCT00510146 ·Status: COMPLETED ·Phase: PHASE3
-
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
NCT01246232 ·Status: COMPLETED ·Phase: PHASE4